Behavioral and prolactin responses to 5-hydroxytrytophan in rats treated during development with 5,7-dihydroxytryptamine

George R. Breese, Richard A. Vogel, Cynthia M. Kuhn, Richard Mailman, Robert A. Mueller, Saul M. Schanberg

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The serotonin precursor, 5-hydroxytryptophan (5-HTP), can induce a behavioral syndrome characterized by rigidity, splayed feet, tremor, head weaving, saliva and forepaw treading. This response to 5-HTP was markedly potentiated in adult rats treated intracisternally with 5,7-dyhydroxytryptamine (5,7-DHT) during development. Prevention of the 5,7-DHT-induced reduction of brain norepinephrine with pargyline or desipramine did not diminish the potentiationof 5-HTP, suggesting that noradrenergic fibers are not contributing to the altered 5-HTP response. It was also found that treatments with 5,7-DHT potentiated the release of prolactin and the disruption of responding in a fixed-ratio operant task induced by 5-HTP. Other experiments indicated that 5,7-DHT treatments potentiated 5-HTP without affecting the action of l-dihydroxyphenylalamine. In addition, administration of the decarboxylase inhibitor, R0-4-4602, at a dose that inhibits enzyme activity in brain, blocked the 5-HTP-induced behavioral syndrome in 5,7-DHT-treated rats, indicating that 5-HTP must be converted to serotonin for 5-HTP to alter behavior. Thus, the present studies indicate that destruction of setonertic fibers during development can produce permanent changes in central serotonergic mechanisms.

Original languageEnglish (US)
Pages (from-to)263-275
Number of pages13
JournalBrain research
Volume155
Issue number2
DOIs
StatePublished - Oct 27 1978

Fingerprint

5,7-Dihydroxytryptamine
5-Hydroxytryptophan
Prolactin
Serotonin
Pargyline
Desipramine
Carboxy-Lyases
Brain
Tremor
Saliva
Foot
Norepinephrine
Head

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Breese, George R. ; Vogel, Richard A. ; Kuhn, Cynthia M. ; Mailman, Richard ; Mueller, Robert A. ; Schanberg, Saul M. / Behavioral and prolactin responses to 5-hydroxytrytophan in rats treated during development with 5,7-dihydroxytryptamine. In: Brain research. 1978 ; Vol. 155, No. 2. pp. 263-275.
@article{3ebd22b380b64201896e9d0d5b046887,
title = "Behavioral and prolactin responses to 5-hydroxytrytophan in rats treated during development with 5,7-dihydroxytryptamine",
abstract = "The serotonin precursor, 5-hydroxytryptophan (5-HTP), can induce a behavioral syndrome characterized by rigidity, splayed feet, tremor, head weaving, saliva and forepaw treading. This response to 5-HTP was markedly potentiated in adult rats treated intracisternally with 5,7-dyhydroxytryptamine (5,7-DHT) during development. Prevention of the 5,7-DHT-induced reduction of brain norepinephrine with pargyline or desipramine did not diminish the potentiationof 5-HTP, suggesting that noradrenergic fibers are not contributing to the altered 5-HTP response. It was also found that treatments with 5,7-DHT potentiated the release of prolactin and the disruption of responding in a fixed-ratio operant task induced by 5-HTP. Other experiments indicated that 5,7-DHT treatments potentiated 5-HTP without affecting the action of l-dihydroxyphenylalamine. In addition, administration of the decarboxylase inhibitor, R0-4-4602, at a dose that inhibits enzyme activity in brain, blocked the 5-HTP-induced behavioral syndrome in 5,7-DHT-treated rats, indicating that 5-HTP must be converted to serotonin for 5-HTP to alter behavior. Thus, the present studies indicate that destruction of setonertic fibers during development can produce permanent changes in central serotonergic mechanisms.",
author = "Breese, {George R.} and Vogel, {Richard A.} and Kuhn, {Cynthia M.} and Richard Mailman and Mueller, {Robert A.} and Schanberg, {Saul M.}",
year = "1978",
month = "10",
day = "27",
doi = "10.1016/0006-8993(78)91022-3",
language = "English (US)",
volume = "155",
pages = "263--275",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

Behavioral and prolactin responses to 5-hydroxytrytophan in rats treated during development with 5,7-dihydroxytryptamine. / Breese, George R.; Vogel, Richard A.; Kuhn, Cynthia M.; Mailman, Richard; Mueller, Robert A.; Schanberg, Saul M.

In: Brain research, Vol. 155, No. 2, 27.10.1978, p. 263-275.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Behavioral and prolactin responses to 5-hydroxytrytophan in rats treated during development with 5,7-dihydroxytryptamine

AU - Breese, George R.

AU - Vogel, Richard A.

AU - Kuhn, Cynthia M.

AU - Mailman, Richard

AU - Mueller, Robert A.

AU - Schanberg, Saul M.

PY - 1978/10/27

Y1 - 1978/10/27

N2 - The serotonin precursor, 5-hydroxytryptophan (5-HTP), can induce a behavioral syndrome characterized by rigidity, splayed feet, tremor, head weaving, saliva and forepaw treading. This response to 5-HTP was markedly potentiated in adult rats treated intracisternally with 5,7-dyhydroxytryptamine (5,7-DHT) during development. Prevention of the 5,7-DHT-induced reduction of brain norepinephrine with pargyline or desipramine did not diminish the potentiationof 5-HTP, suggesting that noradrenergic fibers are not contributing to the altered 5-HTP response. It was also found that treatments with 5,7-DHT potentiated the release of prolactin and the disruption of responding in a fixed-ratio operant task induced by 5-HTP. Other experiments indicated that 5,7-DHT treatments potentiated 5-HTP without affecting the action of l-dihydroxyphenylalamine. In addition, administration of the decarboxylase inhibitor, R0-4-4602, at a dose that inhibits enzyme activity in brain, blocked the 5-HTP-induced behavioral syndrome in 5,7-DHT-treated rats, indicating that 5-HTP must be converted to serotonin for 5-HTP to alter behavior. Thus, the present studies indicate that destruction of setonertic fibers during development can produce permanent changes in central serotonergic mechanisms.

AB - The serotonin precursor, 5-hydroxytryptophan (5-HTP), can induce a behavioral syndrome characterized by rigidity, splayed feet, tremor, head weaving, saliva and forepaw treading. This response to 5-HTP was markedly potentiated in adult rats treated intracisternally with 5,7-dyhydroxytryptamine (5,7-DHT) during development. Prevention of the 5,7-DHT-induced reduction of brain norepinephrine with pargyline or desipramine did not diminish the potentiationof 5-HTP, suggesting that noradrenergic fibers are not contributing to the altered 5-HTP response. It was also found that treatments with 5,7-DHT potentiated the release of prolactin and the disruption of responding in a fixed-ratio operant task induced by 5-HTP. Other experiments indicated that 5,7-DHT treatments potentiated 5-HTP without affecting the action of l-dihydroxyphenylalamine. In addition, administration of the decarboxylase inhibitor, R0-4-4602, at a dose that inhibits enzyme activity in brain, blocked the 5-HTP-induced behavioral syndrome in 5,7-DHT-treated rats, indicating that 5-HTP must be converted to serotonin for 5-HTP to alter behavior. Thus, the present studies indicate that destruction of setonertic fibers during development can produce permanent changes in central serotonergic mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=0017857741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017857741&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(78)91022-3

DO - 10.1016/0006-8993(78)91022-3

M3 - Article

VL - 155

SP - 263

EP - 275

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -